Eli Lilly has partnered with Laekna to advance LAE102, an antibody targeting the ActRIIA receptor, for obesity and muscle ...

LAEKNA-B (02105.HK) announced that it intends to place a total of 17.636 million shares of the company, equivalent to about 4 ...

Laekna, Inc. (HK:2105) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...

Bengaluru: Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help ...

LAEKNA-B (02105.HK) -0.580 (-3.737%) announced a share placing immediately after a 48% share surge yesterday (20th). Today ...

Lilly will provide the funding and expertise to advance Laekna’s LAE102, a first-in-class monoclonal antibody targeting the ...

Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...

Vyriad announced a collaboration with Novartis to develop in vivo CAR T therapies. Eli Lilly teamed up with Chinese biotech ...

You need to be a subscriber to view this content.